Not all are lost: Interrupted laboratory monitoring, early death, and loss to follow-up (LTFU) in a large south african treatment program

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Ahonkhai, Aima A ^a   Noubary, Farzad ^a   Munro, Alison ^b   Stark, Ruth ^c   Wilke, Marisa ^c   Freedberg, Kenneth A ^a,d,e,h   Wood, Robin ^g   Losina, Elena ^e,f,h  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Southern African Catholic Bishops' Conference   (South Africa)

^c Catholic Relief Services South Africa   (South Africa)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e HARVARD UNIVERSITY   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g UNIVERSITY OF CAPE TOWN   (South Africa)

^h BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEALTH CARE AVAILABILITY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT COMPLIANCE; PATIENT MONITORING; RETROSPECTIVE STUDY; RISK ASSESSMENT; SOUTH AFRICA; TREATMENT OUTCOME; URBAN RURAL DIFFERENCE; VIREMIA; VIRUS LOAD; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; STATISTICAL MODEL; STATISTICS;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; LOST TO FOLLOW-UP; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; SOUTH AFRICA;

EID: 84858049856     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032993     Document Type: Article

References (30)

1. Republic of South Africa Country Progress Report on the Declaration of Committment on HIV/AIDS. 2010.
2. Fox MP, Rosen S, (2010) Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Tropical medicine & international health: TM & IH 15 (Suppl 1): 1-15.
3. Rosen S, Fox MP, (2011) Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS medicine 8: e1001056.
4. Brinkhof MW, Pujades-Rodriguez M, Egger M, (2009) Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One 4: e5790.
5. Boulle A, Bock P, Osler M, Cohen K, Channing L, et al. (2008) Antiretroviral therapy and early mortality in South Africa. Bull World Health Organ 86: 678-687.
6. Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, et al. (2009) Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health 9: 290.
7. Geng EH, Nash D, Kambugu A, Zhang Y, Braitstein P, et al. (2010) Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep 7: 234-244.
8. WHO (2010) Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a public health approach.
9. Kranzer K, Ford N, (2011) Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review. Tropical medicine & international health: TM & IH.
10. Mermin J, Ekwaru JP, Were W, Degerman R, Bunnell R, et al. (2011) Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial. BMJ 343: d6792.
11. Mugyenyi P, Walker AS, Hakim J, Munderi P, Gibb DM, et al. (2010) Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet 375: 123-131.
12. Chi BH, Yiannoutsos CT, Westfall AO, Newman JE, Zhou J, et al. (2011) Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America. PLoS medicine 8: e1001111.
13. Stark RDJ, Ford S, Senefeld S, (2010) The AIDS Relief South Africa Partnership Baltimore Catholic Relief Services.
14. WHO (2006) Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a public health approach Geneva.
15. National Department of Health South Africa(2004). National Antiretroviral Treatment Guidelines.
16. Hedeker D, (2003) A mixed-effects multinomial logistic regression model. Stat Med 22: 1433-1446.
17. Cochran WG, (1954) Some methods for strengthening the common chi-square tests. Biometrics 10: 417-451.
18. Armitage P, (1955) Tests for linear trends in proportions and frequencies. Biometrics 11: 375-386.
19. Bland JM, Altman DG, (1995) Multiple significance tests: the Bonferroni method. BMJ 310: 170.
20. Ekouevi DK, Balestre E, Ba-Gomis FO, Eholie SP, Maiga M, et al. (2010) Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa. Trop Med Int Health 15 (Suppl 1): 34-42.
21. Kranzer K, Lewis JJ, Ford N, Zeinecker J, Orrell C, et al. (2010) Treatment interruption in a primary care antiretroviral therapy program in South Africa: cohort analysis of trends and risk factors. J Acquir Immune Defic Syndr 55: e17-23.
22. Bisson GP, Gaolathe T, Gross R, Rollins C, Bellamy S, et al. (2008) Overestimates of survival after HAART: implications for global scale-up efforts. PLoS One 3: e1725.
23. Geng EH, Bangsberg DR, Musinguzi N, Emenyonu N, Bwana MB, et al. (2010) Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr 53: 405-411.
24. Rosen S, Ketlhapile M, (2010) Cost of using a patient tracer to reduce loss to follow-up and ascertain patient status in a large antiretroviral therapy program in Johannesburg, South Africa. Trop Med Int Health 15 (Suppl 1): 98-104.
25. Lawn SD, Myer L, Harling G, Orrell C, Bekker LG, et al. (2006) Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clin Infect Dis 43: 770-776.
26. Rosen S, Fox MP, Gill CJ, (2007) Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 4: e298.
27. Perron NJ, Dao MD, Kossovsky MP, Miserez V, Chuard C, et al. (2010) Reduction of missed appointments at an urban primary care clinic: a randomised controlled study. BMC Fam Pract 11: 79.
28. Martin C, Perfect T, Mantle G, (2005) Non-attendance in primary care: the views of patients and practices on its causes, impact and solutions. Fam Pract 22: 638-643.
29. Mugavero MJ, Lin HY, Willig JH, Westfall AO, Ulett KB, et al. (2009) Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis 48: 248-256.
30. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, et al. (2008) Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ 86: 559-567.